The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...

Kennedy Jr. to significantly reorganize federal health institutions. Peter Marks, the director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, criticized the ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be untreatable, for up to one year. Lipoprotein(a) is a type of cholesterol that ...

The alarm is sounding in the UK's first drug consumption room. A man in his 30s has overdosed in the "using space" – a room in the Glasgow facility where nurses supervise injections in eight booths.

A deadly, drug-resistant fungus that preys on the sick and old is continuing to spread in hospitals and senior care facilities across the country, killing more than 1 in 3 infected. Candida auris ...

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...

Researchers have discovered a new antibiotic molecule that targets a broad range of disease-causing bacteria — even strains resistant to commercial drugs — and is not toxic to human cells 1.

Each member was administered medication, he claimed. The resort released a statement to ABC News on Tuesday, March 25, regarding the family’s reported illness. “The hotel staff dispatched a ...

The Manatee County Sheriff’s Office says it has made the largest fentanyl bust in its history. An accused local drug dealer was arrested in connection with the investigation and deputies are searching ...

But new research on an experimental drug suggests that it could potentially help lower the odds of developing Alzheimer's in people who are genetically predisposed to the devastating condition.

Residents and business owners in San Francisco say recent cleanups have shifted drug-related issues to nearby streets and alleys, worsening their quality of life. Despite a surge in resources and ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020 ...